Ws9326a, a novel tachykinin antagonist isolated from streptomyces violaceusniger no. 9326: II. Biological and pharmacological properties of ws9326a and tetrahydro-ws9326a (fk224)

37Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

Abstract

WS9326A binds competitively to [3H]substance P (NK-1 receptor) binding sites on guinea-pig lung membranes (IC50 = 3.6× 10-6m), and acts as a tachykinin antagonist in various functional assays. WS9326A inhibited tracheal constrictions produced by exogenously added substance P and neurokinin A, with IC50 values of 9.7 × 10-6m and 3.5 × 10-6m, respectively. WS9326A inhibited neurokinin A-induced bronchoconstriction in a dose dependent manner when administered to guinea-pigs intravenously together with neurokinin A, and was also effective in preventing capsaicin-induced bronchoconstriction, which is known to be caused by release of endogenous tachykinins (substance P and neurokinin A). FK224 (tetrahydro-WS9326A; catalytic hydrogenation of WS9326A gave FK224) was more potent than WS9326A in the [3H]substance P receptor binding assay using guinea-pig lung membrane (IC50= 1.0 × 10-7 m). © 1992, JAPAN ANTIBIOTICS RESEARCH ASSOCIATION. All rights reserved.

Cite

CITATION STYLE

APA

Hashimoto, M., Hayashi, K., Murai, M., Fujii, T., Nlshikawa, M., Klyoto, S., … Imanaka, H. (1992). Ws9326a, a novel tachykinin antagonist isolated from streptomyces violaceusniger no. 9326: II. Biological and pharmacological properties of ws9326a and tetrahydro-ws9326a (fk224). The Journal of Antibiotics, 45(7), 1064–1070. https://doi.org/10.7164/antibiotics.45.1064

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free